Relmada Announces FDA Fast Track Designation for d-Methadone for Adjunctive Treatment of Major Depressive Disorder

See more here


MD Anderson, Oncora Medical team up to fight cancer with precision medicine alliance

See more here


GenPro and Helen F. Graham Cancer Center Present A Novel Epigenetic Biomarker Discovery Approach to a Potential Prognostic Marker for Triple Negative Breast Cancer at NAACR Conference in Washington DC on April 1-4, 2017

See more here


Intezyne Technologies Initiates First-In-Human Trials for Topoisomerase-1 Inhibitor IT-141; GRP78 Inhibitor IT-139 to be Featured in AACR Symposium 

See more here


QR Pharma, Inc. Presents New Data on Posiphen in Alzheimer’s and Parkinson’s Disease at the 13th AD/PD International Conference

See more here


Immigrant-founded Keriton raised $1 million to help keep premature babies on breast milk 

See more here


Ossianix receives milestone payment from Lundbeck for blood-brain barrier (BBB) antibody delivery technology

See more here


Relmada Announces FDA Acceptance of IND and Authorization to Commence Phase 2a Clinical Trial for d-Methadone

See more here